The diabetic medicine " Wen DiYa " The USA and Europe is limited

The diabetic medicine " Wen DiYa " The USA and Europe is limited
The diabetic medicine " Wen DiYa " The USA and Europe is limited
Special despatch Europe and American medicine regulator announced www.xinhuanet.com Beijing a few days ago on September 24, because the diabetic medicine document guides refined(A v a n d i a)s There is risk which initiates cardiovascular vessel disease, the sale of this kind of medicine will be forbidden and limited in U.S.A. in Europe. It is a diabetic medicine that Ge Lan plain SmithKline company put out in 1999 that the document guides refinedly. Much pieces of research have revealed, it will increase the risk that people suffer from heart disease recently, assessed in a plurality of countries again. U.S.A. once released the health to warn on this medicines in 2007. European medicines administration bureau proposes suspending the document and guiding refined sale in a statement on the 23rd. The declaration says, " it proves this kind of medicine is greater than the risk to the utility of one patient's colony to present the reliable materials " Before this, this sells the prohibition and continues carrying out. American Food and Drug Administration determines to restrain the document from guiding refined sale strictly too on the 23rd, but not totally forbidden. American medicine in charge of office say, have information reveal, take article guide the refined diabetic, " suffer from the intersection of cardiovascular vessel and disease, for example increase in risk of heart disease " . This organization proposes, are only taking this kind of medicine when being unable to control the blood glucose level via other means as to American patient of the I I -type diabetes of new trouble. And to the patient taking this kind of medicine, they can choose whether to continue using or not by oneself. (End)


|